Endogenous subclinical hyperthyroidism and cardiovascular system: Time to reconsider?

International Journal of Cardiology

Volumn 149, Issue 1, 2011, Pages 108-109

  Patanè, Salvatore ^a   Marte, Filippo ^a   Sturiale, Mauro ^b  

^a Cardiologia Nuovo Presidio Ospedaliero Cutroni Zodda Barcellona PdG ^*  (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Hyperthyroidism; L thyroxine; Thromboembolic risk; Thyroiditis

Indexed keywords

D DIMER; FIBRINOGEN; LEVOTHYROXINE; LIOTHYRONINE; THYROTROPIN; THYROXINE; VON WILLEBRAND FACTOR;

ACUTE HEART INFARCTION; CARDIOVASCULAR SYSTEM; CORONARY ARTERY OBSTRUCTION; ENDEMIC GOITER; EUTHYROIDISM; EXERCISE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTHYROIDISM; LETTER; LIOTHYRONINE BLOOD LEVEL; LUNG EMBOLISM; PREVALENCE; PRIORITY JOURNAL; THROMBOEMBOLISM; THYROID NODULE; THYROIDITIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 79955939949     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.05.014     Document Type: Article

References (28)

1. Duggal J, Singh S, Barsano CP, Arora R.Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism: pathophysiology and management. J Cardiometab Syndr. 2007 Summer; 2(3): 198-206. Review.
2. Singh S, Duggal J, Molnar J, Maldonado F, Barsano CP, Arora R. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-causemortality: a meta-analysis. Int J CardiolMar 28 2008;125(1):41-8 Electronic Publication ahead of print 2007 Apr 16.
3. Biondi B, Palmieri EA, Lombardi G, Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med. Dec 3 2002 ;137(11):904-14. Review.
4. Shrier DK, Burman KD. Subclinical hyperthyroidism: controversies in management. Am Fam Physician Feb 1 2002;65(3):431-8. (Pubitemid 34174020)
5. Batrinos ML. The problem of exogenous subclinical hyperthyroidism. Hormones (Athens). Apr-Jun 2006;5(2):119-25. Review. Erratum in: Hormones (Athens). 2006 Oct-Dec;5(4):following 311.
6. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol. Jan 2005;152 (1):1-9. Review.
7. Cooper DS. Approach to the patient with subclinical hyperthyroidism. J Clin Endocrinol Metab Jan 2007;92(1):3-9.
8. Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab Dec 2000;85(12):4701-5. (Pubitemid 32157655)
9. Chuhwak EK, Anjorin FI, Ohwovoriole AE. Reduced thyrotropin in euthyroid goitrous patients suggesting subclinical hyperthyroidism. Niger J Med Apr-Jun 2007;16(2):133-7.
10. Tollin SR, Fallon EF, Mikhail M, Goldstein H, Yung E. The utility of thyroid nuclear imaging and other studies in the detection and treatment of underlying thyroid abnormalities in patients with endogenous subclinical thyrotoxicosis. Clin Nucl Med May 2000;25(5):341-7. (Pubitemid 30226863)
11. Burmeister LA, Flores A. Subclinical thyrotoxicosis and the heart.Thyroid. 2002 Jun;12(6):495-9. Review.
12. Psaltopoulou T, Ilias I, Toumanidis S, et al. Endogenous subclinical hyperthyroidism: Metabolic and cardiac parameters. Eur J Intern Med Sep 2007;18(5):423-9 Electronic Publication ahead of print 2007 Jun 27.
13. Franklyn JA. Subclinical thyroid disorders-consequences and implications for treatment. Ann Endocrinol (Paris). Sep 2007;68(4):229-30. Electronic Publication ahead of print 2007 Jul 24. Review.
14. Petretta M, Bonaduce D, Spinelli L, et al. Cardiovascular haemodynamics and cardiac autonomic control in patients with subclinical and overt hyperthyroidism. Eur J Endocrinol 2001;145:691-6. (Pubitemid 33133674)
15. Biondi B. Should we treat all subjects with subclinical thyroid disease the same way? Eur J Endocrinol Sep 2008;159(3):343-5 Electronic publication 2008 Jul 22.
16. Haentjens P, Van Meerhaeghe A, Poppe K, Velkeniers B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur J Endocrinol Sep 2008;159(3):329-41 Electronic publication 2008 May 29.
17. Patanè S, Marte F, Di Bella G, Turiano G. Acutemyocardial infarction and subclinical hyperthyroidism without significant coronary stenoses. Int J Cardiol 2009 May 29;134(3):e135-7 [Electronic Publication ahead of print 2008 Jun 24].
18. Patanè S, Marte F. Paroxysmal atrial fibrillation during acute myocardial infarction associated with subclinical hyperthyroidism, severe three vessels coronary artery disease and elevation of prostate-specific antigen after Turp. Int J Cardiol 2010;138:e28-30.
19. Patanè S, Marte F. Paroxysmal ventricular tachycardia and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism, chronic renal failure and elevation of prostate-specific antigen during acute myocardial infarction. Int J Cardiol 2010 Feb 4;138(3):e44-6 [Electronic Publication ahead of print 2008 Aug 21].
20. Patanè S, Marte F. Atrial fibrillation associated with subclinical hyperthyroidism. Int J Cardiol 2009 May 29;134(3):e155-8 [Electronic Publication ahead of print 2009 Jan 29].
21. Patanè S, Marte F. Intermittent changing axis deviationwith intermittent left anterior hemiblock during atrial flutter with subclinical hyperthyroidism. Int J Cardiol 2009 Jun 26;135(2):e37-9 [Electronic Publication ahead of print 2008 Jan 24].
22. Patanè S, Marte F. Changing axis deviation and paroxysmal atrial flutter associated with subclinical hyperthyroidism. Int J Cardiol 2010 Oct 8;144(2):e31-3 [Electronic Publication ahead of print 2009 Jan 26].
23. Erem C. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Clin Endocrinol (Oxf) Mar 2006;64(3):323-9.
24. Coban E, Aydemir M, Yazicioglu G, Ozdogan M. Endothelial dysfunction in subjects with subclinical hyperthyroidism. J Endocrinol Invest Mar 2006;29(3):197-200.
25. Coban E, Aydemir M. Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism. Med Sci Monit Jan 2008;14(1):CR42-46.
26. Patanè S, Marte F. Atrial fibrillation and acute myocardial infarction without significant coronary stenoses associated with subclinical hyperthyroidism and erythrocytosis. Int J Cardiol 2010 Nov 5;145(1):e36-9 [Electronic Publication ahead of print 2009 Jan 30].
27. Patanè S, Marte F, Currò A, Cimino C. Recurrent acute pulmonary embolism and paroxysmal atrial fibrillation associated with subclinical hyperthyroidism. Int J Cardiol 2010 Jul 9;142(2):e25-6 [Electronic Publication ahead of print 2009 Jan 9].
28. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.